Downstream Manufacturing Solutions
-
Sterile Fill/Finish Services
3/25/2025
Our 87,000 sq. ft. cGMP-certified drug product manufacturing facility, located in Baltimore, Maryland, offers aseptic fill/finish manufacturing of biologics and sterile injectables.
-
Making Success More Certain
3/25/2025
As a leading CDMO, we specialize in the development and manufacturing of diverse dosage forms for both clinical and commercial applications, driven by a culture of innovation and commitment to quality.
-
Looking For A More Affordable Source Of Protein A Resin?
3/14/2025
Optimize antibody purification with high-performance affinity resins. Improve efficiency, and scalability while maintaining excellent binding capacity and stability for reliable downstream processing.
-
High Quality Water: Cell Culture Grade, Molecular Biology Grade, Reagent Grade
3/12/2025
Corning's high-quality water, produced in a compliant facility, meets industry standards for purity. Available in various sizes, it supports bioprocessing and reagent preparation while reducing costs.
-
Exploring A Modular, Scalable Platform For Adherent Cell Culture
3/12/2025
The Corning CellCube system enables scalable adherent cell culture with modular plates, optimized media recirculation, and aseptic connections. It supports seamless scale-up with sterile, ready-to-use modules.
-
Advanced Automation System For Flexible Aseptic Filling
2/24/2025
Discover a gloveless system designed to provide an optimal aseptic process with a standardized flexible filler capable of producing vials, syringes and cartridges.
-
Protein A Resin With High Binding Capacity
2/21/2025
Protein A resin with high binding capacity for cost-efficient separation mAbs.
-
Aseptic Filling Qualification Solutions
2/19/2025
Standardize your approach to qualification with aseptic filling equipment that comes with comprehensive documentation, testing protocols, and training to enhance efficiency and regulatory compliance.
-
Protein A Mix-N-Go™ ELISA Kits
2/18/2025
Mix-N-Go™ ELISA kits are designed to perform with most natural and recombinant Protein A constructs and incorporate the revolutionary single step sample treatment procedure. These kits also reduce the complexity of the assay and time to result while increasing the robustness of the method over traditional Protein A ELISAs.
-
Outsource To The Experts In Biopharmaceutical Impurity Analysis
2/18/2025
Ensure the purity and safety of your biopharmaceuticals with expert impurity analysis solutions — featuring ELISA kits, orthogonal testing, automation, and custom services for all major expression systems.